Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06562582 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

STunning in Acute Myocardial Infarction - BAS

Study acronym: STAMI-BAS
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 9 words
  2. 2 versions Re-verified since Apr 1, 2025, no change to tracked fieldsv4-v5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 1, 2024 to Jan 6, 2025
    • Study sites: 0 to 1
    v3
  4. Primary endpoint revised
    • Secondary endpoints revised (4)
    • Study title shortened, about 12 words
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this trial is to examine the effect of immediate versus late administration of beta blockers, angiotensin converting enzyme inhibitors (ACEI), and sodium/glucose cotransporter 2 (SGLT2) inhibitors on echocardiographic parameters and biomarkers in subjects with ST-elevation myocardial infarction (STEMI)
Trial Details
NCT Number NCT06562582
Lead Sponsor Vastra Gotaland Region
Conditions
(from sponsor)		 Myocardial Infarct
Related terms Myocardial Infarction
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov